154 related articles for article (PubMed ID: 11759055)
21. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
[TBL] [Abstract][Full Text] [Related]
22. So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity.
Chang A; Schuetze SM; Conrad EU; Swisshelm KL; Norwood TH; Rubin BP
Int J Surg Pathol; 2005 Apr; 13(2):185-95. PubMed ID: 15864383
[TBL] [Abstract][Full Text] [Related]
23. Expression of myogenic marker proteins in human leiomyosarcoma.
Meyer T; Brinck U
APMIS; 1997 Oct; 105(10):793-800. PubMed ID: 9368594
[TBL] [Abstract][Full Text] [Related]
24. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
25. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
[TBL] [Abstract][Full Text] [Related]
26. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody.
Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG
Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600
[TBL] [Abstract][Full Text] [Related]
27. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
Rush DS; Tan J; Baergen RN; Soslow RA
Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
[TBL] [Abstract][Full Text] [Related]
28. The immunohistochemical profile of oral inflammatory myofibroblastic tumors.
Salgueiredo-Giudice F; Fornias-Sperandio F; Martins-Pereira E; da Costa dal Vechio AM; de Sousa SC; dos Santos-Pinto-Junior D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):749-56. PubMed ID: 21459633
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
Shintaku M; Fukushima A
Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
[TBL] [Abstract][Full Text] [Related]
30. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
Coco DP; Hirsch MS; Hornick JL
Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
32. Specificity and sensitivity of differentiation antigens in superficial soft tissue tumors: comparison of SMA, calponin, H-caldesmon, C-kit, PLAP and HPL.
Durak H; Comunoglu NU; Comunoglu C; Guven A; Cam M; Dervisoglu S; Eren B
Bratisl Lek Listy; 2010; 111(8):432-8. PubMed ID: 21033622
[TBL] [Abstract][Full Text] [Related]
33. Calponin and h-caldesmon expression in synovial sarcoma; the use of calponin in diagnosis.
Fisher C; Montgomery E; Healy V
Histopathology; 2003 Jun; 42(6):588-93. PubMed ID: 12786895
[TBL] [Abstract][Full Text] [Related]
34. Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa.
Silva EG; Deavers MT; Bodurka DC; Malpica A
Am J Surg Pathol; 2004 Feb; 28(2):244-9. PubMed ID: 15043315
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin.
Frid MG; Shekhonin BV; Koteliansky VE; Glukhova MA
Dev Biol; 1992 Oct; 153(2):185-93. PubMed ID: 1397676
[TBL] [Abstract][Full Text] [Related]
36. Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases.
Gupta S; Jimenez RE; Folpe AL; Cheville JC
Am J Surg Pathol; 2016 Nov; 40(11):1557-1563. PubMed ID: 27276240
[TBL] [Abstract][Full Text] [Related]
37. Mixed tumors of the vagina: an immunohistochemical study of 13 cases with emphasis on the cell of origin and potential aid in differential diagnosis.
Oliva E; Gonzalez L; Dionigi A; Young RH
Mod Pathol; 2004 Oct; 17(10):1243-50. PubMed ID: 15154010
[TBL] [Abstract][Full Text] [Related]
38. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
[TBL] [Abstract][Full Text] [Related]
39. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
